Career Development Award
Helps fellowship for early-career lung-cancer researchers through the Career Development Award.
⚠This may reflect a past cycle — verify the current call on the funder's site.
The LUNGevity Foundation Career Development Award (CDA) is a three-year research grant of $300,000 (paid at $100,000 per year) for early-career investigators at US academic or research institutions working on lung cancer early detection or individualised treatment, including targeted therapy and immunotherapy. LUNGevity Foundation is a US nonprofit focused exclusively on lung cancer research, survivorship, and advocacy, and the CDA is its flagship career-building mechanism. The award is designed to establish the investigator's independent research programme in lung cancer science.
Eligibility requires a doctoral degree, completion of postdoctoral training, and a current position within the first five years of the applicant's initial faculty appointment at a qualifying US academic or research institution. No more than one CDA may be awarded per institution in a single cycle. A formal mentoring plan identifying senior scientific mentors is a required component of the application. The 2026 cycle followed a two-step process via the proposalCENTRAL platform: the letter of intent (LOI) was due February 17, 2026, invited full applications were due May 11, 2026, award announcements are expected in late summer 2026, and funded projects start November 1, 2026. Applications are reviewed by LUNGevity's Scientific Advisory Board.
Competitive applications combine a novel scientific hypothesis within the early-detection or individualised-treatment scope, a credible mentoring network, and a clear career-development trajectory. Because only one award per institution is permitted, internal competition at larger research universities may occur before external submission. Applicants should confirm institutional eligibility and coordinate with a sponsored programmes office well in advance of the proposalCENTRAL LOI deadline for future cycles.
Three-year career development awards for early-career investigators at US academic institutions pursuing lung cancer early detection or individualized treatment research including targeted therapy and immunotherapy.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline